About Ignite Proteomics LLC
Ignite Proteomics, LLC is a cancer diagnostics company that provides protein biomarker analysis services for treatment selection and drug response prediction in oncology. The company operates a CLIA-accredited laboratory and offers a 32-analyte Reverse Phase Protein Array assay combined with laser capture microdissection technology to assess the activated proteome and phosphoprotein status in tumor samples. Ignite's assay provides pathway-based analysis to support treatment decision-making for physicians and enables therapeutic development support for pharmaceutical companies in oncology and immuno-oncology applications. The company was founded in 2024 and is headquartered in Golden, Colorado, United States